NVO241220P75000
- 0.01
- 0.000.00%
Novo-Nordisk A/S Newsroom
Novo Nordisk A/S (NVO): A Bull Case Theory
Veru Surges as It Sells FC2 Female Condom Business to Private Investors
European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading
Lilly and Novo Went Head-to-Head Over Weight-Loss Drugs in 2024. There's a Clear Winner. -- Barrons.com
Top Gap Ups and Downs on Monday: AR, DJT, MSTR and More
Is Novo Nordisk A/S (NVO) the Best Pharma Dividend Stock to Buy In 2024?
Novo Nordisk's Options: A Look at What the Big Money Is Thinking
In 2024, Eli Lilly and Co (LLY.US) shines brightly while Novo-Nordisk A/S (NVO.US) fades into the background.
As the year comes to a close, Wall Street has listed Eli Lilly and Co (LLY.US) as one of the best-performing companies among large pharmaceutical firms, while Novo-Nordisk A/S (NVO.US) has lagged due to a bleak outlook.
Eli Lilly to End 2024 Among Best in Big Pharma; Novo Among Worst
Elon Musk Admits To Using Weight Loss Medication Criticized By RFK Jr, Says He Prefers Mounjaro Over Miracle Drug Ozempic
Behind the Scenes of Novo Nordisk's Latest Options Trends
Here's Why Novo Nordisk A/S (NVO) Slid in Q3
US MOVERS&SHAKERS Dec 23-Dec 27, 2024
3 Healthcare Stocks to Buy for a 2025 Rebound
Top Gap Ups and Downs on Thursday: TM, LI, KB and More
Novo-Nordisk A/S faces another blow: Musk shares a weight loss photo, claiming that using Eli Lilly and Co's weight loss drug is more effective than semaglutide.
On Christmas, Musk shared a photo and called himself the Ozempic Santa Claus, clarifying that he didn't mean the drug name Ozempic for semaglutide, but rather Eli Lilly and Co's competitor Mounjaro. He also mentioned that "high doses" of Ozempic would make him fart and burp, adding that "Mounjaro seems to have fewer side effects and is more effective."
Novo-Nordisk A/S Options Spot-On: On December 26th, 96,143 Contracts Were Traded, With 459.29K Open Interest
Musk Tests Mounjaro, Ozempic, Wegovy: Which Weight-Loss Drug Won Him Over?
Musk revealed that he switched to using Eli Lilly and Co's weight loss medication: the effect is better than Novo-Nordisk A/S's competing products, with fewer side effects.
① The world's richest man Elon Musk confirmed on the Social Media platform X on Wednesday that he is using Eli Lilly and Co's Mounjaro for weight loss; ② Musk revealed that he initially tried using Novo-Nordisk A/S's Ozempic for weight loss, but switched to Mounjaro due to significant side effects.
Musk "endorses" Eli Lilly and Co (LLY.US) weight loss drug: Mounjaro has fewer side effects and better results.
On Wednesday, Musk posted on the X platform emphasizing that he prefers Eli Lilly and Co's product Mounjaro over Novo-Nordisk A/S's weight loss treatment Ozempic.